{"name":"River 2 Renal Corp.","slug":"river-2-renal-corp","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiYEFVX3lxTFBKSDAzalY3NmwyOERrNGdDR2I4Z0s1VnBWNGFON3ZBWllqNjdCQm9KdjQtbk43WGFWd0tKLXNONmJqYkc1T05sUzVjLVVQd19UNVpoaTJHeWw2Vkx2OWxyUg?oc=5","date":"2026-03-27","type":"pipeline","source":"JACC Journals","summary":"Effects of Finerenone on Heart Failure Outcomes According to Baseline Heart Failure Risk in Chronic Kidney Disease and Type 2 Diabetes - JACC Journals","headline":"Effects of Finerenone on Heart Failure Outcomes According to Baseline Heart Failure Risk in Chronic Kidney Disease and T","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiaEFVX3lxTE5IQmUzenFyWVNRbWlVVjRpS1VuSm5FcFRzdkJMQm4xVFM3ekU4Vmd6Y3RmTW5KbVNaYXBaM0ItRWdMN18wbU91eHJicXlCOWdhMHZDUUNSRU5hS1pRbVpKNVpCdmtyR2c3?oc=5","date":"2025-07-24","type":"trial","source":"Wiley Online Library","summary":"Bradycardia and Other Arrhythmias in Patients With Hepatorenal Syndrome-Acute Kidney Injury Following Terlipressin Treatment: A Pooled Analysis of Three North American Phase III Clinical Studies - Wil","headline":"Bradycardia and Other Arrhythmias in Patients With Hepatorenal Syndrome-Acute Kidney Injury Following Terlipressin Treat","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTFBrOTk5RlVjbFVFSkxNckhYQ1VwQURKZm1fZ2tCdnYwdGJablFsNFpqcFZ5ZjFVcWhvT19LYXJreGVDbU1qakhydkpuRDNtMUw4anNldUpVUm96TzhyYUE4?oc=5","date":"2024-09-01","type":"pipeline","source":"Nature","summary":"Finerenone in heart failure and chronic kidney disease with type 2 diabetes: FINE-HEART pooled analysis of cardiovascular, kidney and mortality outcomes - Nature","headline":"Finerenone in heart failure and chronic kidney disease with type 2 diabetes: FINE-HEART pooled analysis of cardiovascula","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiYEFVX3lxTE9PZjJmN0xkNTFacHU1N0x4MjQ1ckU2dWkxbFFKTmhJMmxJUUxvaHBWM2lSQTlkUUpfNXhCdGRBSjdCWTFMaWJ0ZEpIUkFMVnFfTElJODBhLUMyaFR0djNwZw?oc=5","date":"2024-09-01","type":"pipeline","source":"JACC Journals","summary":"Why Has it Been Challenging to Modify Kidney Disease Progression in Patients With Heart Failure? - JACC Journals","headline":"Why Has it Been Challenging to Modify Kidney Disease Progression in Patients With Heart Failure?","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2024-01-10","type":"pipeline","source":"PR Newswire","summary":"Focal Segmental Glomerulosclerosis Market to Observe Impressive Growth by 2032, Predicts DelveInsight | Leading Companies - ACELYRIN, Genentech, ChemoCentryx, Travere Therapeutics, Boehringer Ingelhei","headline":"Focal Segmental Glomerulosclerosis Market to Observe Impressive Growth by 2032, Predicts DelveInsight | Leading Companie","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipgFBVV95cUxNNTVqVVhxYUhsVGRMVlBpSlBFbW91ZUdSWm9mUlZFZlBPRnZfOW5JTXc1UzMtZ1RXSXBCTlNua1NYbENBR1A4WXdqR05VZG9hWW5GMTd1d3JhYWx4UEpEaTV4bmNWZWxVOFJNOFN0ME80dkN2enJIcGM0TVBoU0lKMEtJMDZfekM0bVNMUGE1Mnl3dFZvRTFObUFGWEUtSFR6QzE4bzNB?oc=5","date":"2017-05-08","type":"deal","source":"Fierce Biotech","summary":"Horizon Pharma buys River Vision and its fast-tracked eye med for $145M - Fierce Biotech","headline":"Horizon Pharma buys River Vision and its fast-tracked eye med for $145M","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}